CEACAM5 and neoplasm: Since previous studies have demonstrated an association between tumor burden and amount of soluble CEA in the blood [50], which can eventually alter the biodistribution profile, a second biodistribution study was performed on mice bearing smaller tumors (137 ± 32 mm3, 103 ± 0.02 mg, Figure 1d), representative of the therapeutic setting.